Level C· Early human research exploring benefitsCohort StudyEurope PMCOpen access

Whole-genome sequencing reveals novel genes in ossification of the posterior longitudinal ligament of the thoracic spine in the Chinese population

Liang C., Wang P., Liu X., Yang C., Ma Y., Yong L.

Cohort Study on Ligament Injury, published in J Orthop Surg Res (2018) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Cohort Study
Journal
J Orthop Surg Res (2018)
Reported sample size
—
Source database
Europe PMC
PMID
30577800
PMCID
PMC6303868
DOI
10.1186/s13018-018-1022-8
Citations
12

Abstract (original English)

Background Ossification of the posterior longitudinal ligament (OPLL) of the spine is a complex, multifactorial disease. Although several genes that are linked to cervical OPLL susceptibility have been reported, specific genetic studies regarding thoracic OPLL are lacking. Whole-genome sequencing has been considered as an efficient strategy to search for disease-causing genes. Methods We analysed whole-genome sequences in a cohort of 25 unrelated patients with thoracic OPLL. Bioinformatics analysis and various algorithms were used to predict deleterious variants. Sanger sequencing was used to confirm the variants. Results Four deleterious mutations in three genes (c.2716C>T (p.Arg906Cys) in collagen type VI α6 (COL6A6); c.1946G>C (p.Gly649Ala) in collagen type IX α1 (COL9A1); and c.301T>C (p.Ser101Pro) and c.171A>G (p.Ile57Met) in toll-like receptor 1 (TLR1)) were successfully identified. All the variants were confirmed by Sanger sequencing. Conclusion The novel deleterious mutations of the three genes may contribute to the development of thoracic OPLL.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Thoracic VertebraeHumansOssification of Posterior Longitudinal LigamentGenetic Predisposition to DiseaseCollagen Type VICollagen Type IXComputational BiologyGenotypeMutationAdult

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research